BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18223320)

  • 1. New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.
    Karanjawala ZE; Illei PB; Ashfaq R; Infante JR; Murphy K; Pandey A; Schulick R; Winter J; Sharma R; Maitra A; Goggins M; Hruban RH
    Am J Surg Pathol; 2008 Feb; 32(2):188-96. PubMed ID: 18223320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
    Tsukahara M; Nagai H; Kamiakito T; Kawata H; Takayashiki N; Saito K; Tanaka A
    Pathol Int; 2005 Feb; 55(2):63-9. PubMed ID: 15693851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-18 is an early-stage marker of pancreatic carcinogenesis.
    Tanaka M; Shibahara J; Fukushima N; Shinozaki A; Umeda M; Ishikawa S; Kokudo N; Fukayama M
    J Histochem Cytochem; 2011 Oct; 59(10):942-52. PubMed ID: 21832145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
    Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
    PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.
    Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F
    Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells.
    Salaria SN; Illei P; Sharma R; Walter KM; Klein AP; Eshleman JR; Maitra A; Schulick R; Winter J; Ouellette MM; Goggins M; Hruban R
    Cancer Biol Ther; 2007 Mar; 6(3):324-8. PubMed ID: 17404500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma.
    Fukushima N; Koopmann J; Sato N; Prasad N; Carvalho R; Leach SD; Hruban RH; Goggins M
    Mod Pathol; 2005 Jun; 18(6):779-87. PubMed ID: 15791284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer.
    Pimiento JM; Chen DT; Centeno BA; Davis-Yadley AH; Husain K; Fulp WJ; Wang C; Zhang A; Malafa MP
    Pancreas; 2015 Jan; 44(1):122-7. PubMed ID: 25268673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NBL1 and anillin (ANLN) genes over-expression in pancreatic carcinoma.
    Olakowski M; Tyszkiewicz T; Jarzab M; Król R; Oczko-Wojciechowska M; Kowalska M; Kowal M; Gala GM; Kajor M; Lange D; Chmielik E; Gubala E; Lampe P; Jarzab B
    Folia Histochem Cytobiol; 2009; 47(2):249-55. PubMed ID: 19995712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation.
    Soini Y; Takasawa A; Eskelinen M; Juvonen P; Kärjä V; Hasegawa T; Murata M; Tanaka S; Kojima T; Sawada N
    J Clin Pathol; 2012 May; 65(5):431-6. PubMed ID: 22396552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal responses to carcinomas of the pancreas: juxtatumoral gene expression conforms to the infiltrating pattern and not the biologic subtype.
    Ricci F; Kern SE; Hruban RH; Iacobuzio-Donahue CA
    Cancer Biol Ther; 2005 Mar; 4(3):302-7. PubMed ID: 15876873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags.
    Cao D; Hustinx SR; Sui G; Bala P; Sato N; Martin S; Maitra A; Murphy KM; Cameron JL; Yeo CJ; Kern SE; Goggins M; Pandey A; Hruban RH
    Cancer Biol Ther; 2004 Nov; 3(11):1081-9; discussion 1090-1. PubMed ID: 15467436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Claudin expression in pancreatic endocrine tumors as compared with ductal adenocarcinomas.
    Borka K; Kaliszky P; Szabó E; Lotz G; Kupcsulik P; Schaff Z; Kiss A
    Virchows Arch; 2007 May; 450(5):549-57. PubMed ID: 17429687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47.
    Maitra A; Iacobuzio-Donahue C; Rahman A; Sohn TA; Argani P; Meyer R; Yeo CJ; Cameron JL; Goggins M; Kern SE; Ashfaq R; Hruban RH; Wilentz RE
    Am J Clin Pathol; 2002 Jul; 118(1):52-9. PubMed ID: 12109856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma.
    Grützmann R; Lüttges J; Sipos B; Ammerpohl O; Dobrowolski F; Alldinger I; Kersting S; Ockert D; Koch R; Kalthoff H; Schackert HK; Saeger HD; Klöppel G; Pilarsky C
    Br J Cancer; 2004 Mar; 90(5):1053-8. PubMed ID: 14997207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.
    Mirus JE; Zhang Y; Hollingsworth MA; Solan JL; Lampe PD; Hingorani SR
    Mol Cell Proteomics; 2014 Dec; 13(12):3484-96. PubMed ID: 25225358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target.
    Nichols LS; Ashfaq R; Iacobuzio-Donahue CA
    Am J Clin Pathol; 2004 Feb; 121(2):226-30. PubMed ID: 14983936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
    Shi C; Merchant N; Newsome G; Goldenberg DM; Gold DV
    Arch Pathol Lab Med; 2014 Feb; 138(2):220-8. PubMed ID: 24476519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin A2 and CD105 expression in pancreatic ductal adenocarcinoma is associated with tumor recurrence and prognosis.
    Huang YK; Liu H; Wang XZ; Zhu S
    Asian Pac J Cancer Prev; 2014; 15(22):9921-6. PubMed ID: 25520129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The developmental transcription factor Gata4 is overexpressed in pancreatic ductal adenocarcinoma.
    Karafin MS; Cummings CT; Fu B; Iacobuzio-Donahue CA
    Int J Clin Exp Pathol; 2009 Aug; 3(1):47-55. PubMed ID: 19918328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.